Navigation Links
New Type of Stent Shows Promise
Date:11/11/2008

It recruits blood vessel cells as a kind of heart-healthy coating, experts explain

TUESDAY, Nov. 11 (HealthDay News) -- A new generation of stents shows promise in avoiding the late-onset problems that have plagued drug-eluting stents in patients with heart disease, researchers say.

The tiny mesh tubes that are stents are intended to prop open narrowed arteries, but this new stent works in a novel way. It is coated with an antibody that provokes cells lining artery walls to migrate to and cover the stent, thus speeding the healing process and keeping arteries open longer.

"This is kind of the third-generation stent. One could even call these 'smart' or 'smarter' stents, because they are designed to deal with some of the problems that have existed in the earlier versions," said Dr. Gregory Dehmer, professor of internal medicine at Texas A&M Health Science Center College of Medicine and director of the cardiology division at Scott & White in Temple. "It's an exciting development, but . . . we have to temper our enthusiasm with the growing knowledge that some of the problems with drug-eluting [emitting] stents didn't show up for two to three years."

Even with continued promising results, the new device is likely years away from the U.S. market. "The FDA has largely taken a position of making companies repeat their studies here in the U.S.," said Dr. John P. Reilly, an interventional cardiologist and director of cardiovascular CT at Ochsner Health System in New Orleans. "It will probably be three years before the technology comes to the U.S."

The findings come from two European studies expected to be presented Tuesday and Wednesday at the annual scientific meeting of the American Heart Association, held this year in New Orleans.

Stents are used in patients undergoing angioplasty procedures to reopen narrowed arteries. Bare metal stents were the first to be introduced, but patients often
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Drug-Eluting Stents Beat Bare Metal Stents in Diabetics
2. Coated Stents Best for Heart Patients With Diabetes
3. MDCT: Non-invasive alternative to bronchoscopy in patients with airway stent complications
4. Persistent bacterial infection exploits killing machinery of immune cells
5. First evidence that prenatal exposure to famine may lead to persistent epigenetic changes
6. Tomophase to Exhibit First In-vivo Cross-sectional Images of Pulmonary Stenting Using Proprietary OCT System
7. Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
8. New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management
9. New Type of Stent Appears Safe, Effective
10. MD On-Line Achieves CAQH CORE(TM) Certification for Consistent Healthcare Administrative Data Exchange
11. NYC first: Complex aneurysm treated using new fenestrated endograft stent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Type of Stent Shows Promise
(Date:7/26/2014)... July 26, 2014 According to the ... this is a comprehensive bodybuilding program that helps men ... anabolic steroids . The program also instructs men ... cardio. , Vkool reveals in its review that ... that can help men get ripped and jacked at ...
(Date:7/26/2014)... As the category creator and world leader ... Xoçai is to transform and improve individual ... products. One such unique element is XoVita™, a ... blueberries, an ingredient combination exclusive to Xoçai. This ... all of Xoçai products and provides a wide-ranging ...
(Date:7/25/2014)... 2014 PersonalInjurySolicitorsIreland, a legal claims ... people who have suffered from a variety of ... their new company, and a website, http://www.PersonalInjurySolicitorsIreland.com ... website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law firm ... the company is always on the client, and ...
(Date:7/25/2014)... In recent years, men have become more aware ... symptoms associated with age-related testosterone decline. Amid concerns about testosterone ... case study from Renew Man helps to shed ... using bioidentical hormones. , The case study centers around a ... himself beginning to feel the effects of age-related hormonal decline. ...
(Date:7/25/2014)... July 25, 2014 A federal judge ... in two DePuy Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ... the claims to go before a jury on September ... rendered on July 18th, U.S. District Judge Ed Kinkeade ... two Plaintiffs’ claims may proceed to trial against Johnson ...
Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
... NEW YORK, March 25 As Americans get ... it,s important for men with type 2,diabetes to ... low testosterone than,non-diabetic men., Listen to this ... Registered journalists can access video, audio, text, graphics ...
... In a ceremony,attended by Ohio,s physician leaders, ... of the most sweeping physician-insurance industry,contract reform bills ... law, which will take effect in ninety days, ... the contracting process,fairness in contracting, and a standardized ...
... of a prevention effort , , TUESDAY, March 25 (HealthDay ... to prevent cancer can often be overstated in certain ... a new report claims. , The review, published in ... of the National Cancer Institute , suggests that some ...
... A new study reviewing 75 group-randomized cancer trials over ... those studies used appropriate statistical methods to analyze the ... reported that interventions to prevent disease or reduce cancer ... have been. , More than a third of the ...
... NEW YORK, March 25 North American Insurance,Leaders, Inc. ... of a majority,of the common stock of NAO entitled ... voted against the proposal to consummate a business,combination, as ... Since NAO will not be able to complete ...
... China, March 25 /Xinhua-PRNewswire/ -- China Medicine,Corporation ... "the Company"),a leading developer and distributor of ... medicines (TCM), nutritional and,dietary supplements, medical devices, ... conduct a conference call at 9:00 a.m. ...
Cached Medicine News:Health News:Governor Strickland Signs House Bill 125 Into Law 2Health News:Some Cancer Trials Overstate Findings, Analysis Claims 2Health News:Some Cancer Trials Overstate Findings, Analysis Claims 3Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 2Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 3Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 3
(Date:7/24/2014)... MADISON, Wis. , July 24, 2014 /PRNewswire/ ... provides specialty and compounded pharmaceuticals, announced that it ... sensitivity information unique to each individual based upon ... now possible by understanding the interaction between a ... "We,re very excited to provide this ...
(Date:7/24/2014)... , Germany , and ... -- , Exclusive global license ... for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, ... to be targeted by new test, indicate favorable prognosis ... syndromes  QIAGEN sees potential for developing companion ...
(Date:7/24/2014)... -- Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... financial results for the first fiscal quarter ended June ... Revenues of $47.5 million, up 10% over last year,s ... 50% over last year,s comparable quarter. Revenues ... up 20% over last year,s comparable quarter. , ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... Oct. 12, 2011 Reportlinker.com announces that ... in its catalogue: ... Region 2010-2014 ... the Peripheral Vascular Devices market in the ...
... (NYSE: BSX ) will webcast its conference call ... 2011 on Thursday, October 20, at 8:00 a.m. ET. ... becomes Boston Scientific,s Chief Executive Officer on October 17, and ... A live webcast of the conference call will be ...
Cached Medicine Technology:Peripheral Vascular Device Market in the APAC Region 2010-2014 2Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results 2
The Volk 30D is designed to provide the practitioner a wide field of view with a short working distance. This lens is excellent for use with small pupils....
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
... The Macula Plus® ... detailed observation of the ... macula. Use it with ... for detecting choroidal neovascular ...
... Iris Diagnostics iQ200 Sprint Automated Urine Microscopy ... to the iQ200 Series. The analyzer uses ... to classify urine particles into 12 categories ... eliminates most technologist time used to prepare ...
Medicine Products: